天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

衡陽稼軒生物科技有限公司 Company Information
Company Name:    Hengyang Jiaxuan Biotechnology Co. LTD
Tel:   
Email:    675042965@qq.com
Nationality:    China
WebSite:    http://www.hyjxsw.com
Product List:    308
1 2 3 4
Product List
Cephalexin impurity 3
Pramipexole Related Impurity 2
Moxifloxacin impurities
Moxifloxacin impurities 1394029-14-1
Formyl ciprofloxacin 93594-39-9
Amifostine impurity3
(S)-2,2'-(2-methyl-6-oxopiperazine-1,4-diyl)diacetic acid
ethyl 2-formyl-3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate
Amifostine impurity 1
Gadobutrol Impurity 4
Gadobutrol Impurity 3
Cediranib 288383-20-0
Levofloxacin, chloromethyl ester impurity
Poziotinib 1092364-38-9
Afatinib 439081-18-2
Cabozantinib Malate 1140909-48-3
regorafenib 755037-03-7
Crizotinib 877399-52-5
Cediranib Maleate 857036-77-2
Cephalexin impurity 5 1323247-65-9
Cephalexin S-Sulfoxide 74708-55-7
Cephalexin impurity 6 72820-16-7
Cephalexin impurity L 34632-04-7
Cephalexin R-Sulfoxide 52210-38-5
Lauratinib 1454846-35-5
Pramipexole Related Impurity 1 1244656-98-1
Entrectinib 1108743-60-7
Moxifloxacin Impurity 45
Niraparib tosylate 1613220-15-7
Finasteride 98319-26-7
Bosutinib 380843-75-4
Vandetanib 443913-73-3
AZD3759 1626387-80-1
alectinib 1256580-46-7
axitinib 319460-85-0
Olaparib 763113-22-0
2-(2-NAPHTHYLOXY)ETHANAMINE 23314-24-1
1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-diazinane-2,4,6-trione 19556-63-9
ThiametGDiscontinued 1009816-48-1
SB204741 152239-46-8
1,3,4,6-Tetra-O-acetyl-2-amino-2-deoxy-a-D-glucopyranoseHydrochloride 10034-19-2
treosulfan 299-75-2
3,4-DI-O-ACETYL-6-DEOXY-L-GLUCAL 34819-86-8
9-ALPHA-RIBOFURANOSYLADENINE 5682-25-7
2-Acetamido-1,3,4,6-tetra-O-acetyl-2-deoxy-b-D-galactopyranose 3006-60-8
2-(Acetylamino)-2-deoxy-1-thio-alpha-D-glucopyranose 781581-10-0
Trametinib 871700-17-3
lenvatinib Mesylate 857890-39-2
CapMatinib 1029712-80-8
Nintedanib Ethanesulfonate Salt 656247-18-6
INCB28060 1197376-85-4
Neratinib 698387-09-6
LOXO-101 1223405-08-0
Regorafenib hydrate 1019206-88-2
Pazopanib 444731-52-6
Upadacitinib 1310726-60-3
Selumetinib 606143-52-6
Brigatinib 1197953-54-0
Dabrafenib 1195765-45-7
Dacomitinib 1110813-31-4
Prostaglandin E1 745-65-3
Bimatoprost 155206-00-1
AP 32788 1847461-43-1
Pramipexole Impurity 22
Pramipexole Impurity 16 1373869-91-0
rac-7-Oxo-Pramipexole HCl 1286047-33-3
Decarboxy Moxifloxacin 929102-25-0
(2S,4S)-Argatroban 189264-03-7
7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6-(propylamino)-, (6S)- 2204518-89-6
Benazepril Related Compound F 109010-60-8
Nicorandil EP Impurity C 88598-33-8
Benazepril impurity 1347874-67-2
Nicorandil EP Impurity D 40055-37-6
Dibucaine Impurity C 87864-08-2
Cephalexin 7-Epimer
Geranyl 150995-11-2
Nicorandil EP Impurity A 65141-47-1
Nicorandil EP Impurity B 6265-73-2
Nicorandil Impurity 6
Nicorandil Dimer Bromide 2250142-73-3
Amifostine impurity2 6305-56-2
3-[(2-Hydroxyethyl)amino]propiononitrile 33759-44-3
N-(5-(3-(2-ethoxyphenyl)-3-oxopropanoyl)-1-methyl-3-propyl-1H-pyrazol-4-yl)-2-hydroxybenzamide
R- Dexrazoxane 24613-06-7
Gadobutrol Impurity 2
Gadobutrol Impurity 5 114873-37-9
gadolinium(III) 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetat
(3S,4S)-2-Oxa-8-azaspiro[4.5]decan-4-amine, 3-methyl-, hydrochloride (1:2) 2055761-19-6
ectoine 96702-03-3
2-Pyrazinemethanol 2172651-73-7
(3S,4S)-8-(6-amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine 2,2,2-trifluoroacetate 1801765-04-7
Gadobutrol Impurity 23
Gadobutrol Impurity 11
4-(hydroxyamino)-N-(2-(naphthalen-2-yloxy)ethyl)-N- ((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl) benzenesulfonamide 188480-51-5
(2-chloro-5-iodophenyl)(2-ethoxyphenyl)methanone 2305949-33-9
1-chloro-2-(2-ethoxybenzyl)-4-iodobenzene 2305949-36-2
ethyl 3-oxo-3-(2,4,5-trifluoro-3-methoxyphenyl)propanoate 112811-68-4
((Z)-ethyl 3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate) 866954-86-1
α-L-galactose 15572-79-9
1 2 3 4
Copyright 2007©  ChemicalBook. All rights reserved.